The Stress Peptide CRF Family Expands: New Partners for Anxiety, Depression, and Inflammation

Discovery of new CRF-related peptides (urocortins) and receptor interactions expanded the stress peptide system, revealing distinct roles for CRF1 in anxiety and CRF2 in stress coping, eating, and cardiovascular function.

Dautzenberg, Frank M et al.·Trends in pharmacological sciences·2002·Moderate EvidenceReview
RPEP-00723ReviewModerate Evidence2002RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Expanded CRF peptide family including urocortins reveals distinct CRF1 (anxiety/depression) and CRF2 (stress coping/appetite/cardiovascular) receptor functions, enabling receptor-specific drug development.

Key Numbers

How They Did This

Review of newly discovered CRF-related peptides, receptor characterization, and their roles in stress, anxiety, eating, cardiac, and inflammatory disorders.

Why This Research Matters

Most psychiatric stress research focused on CRF1. The CRF2 receptor's distinct role in stress coping and appetite opens entirely new therapeutic avenues for eating disorders and cardiovascular stress responses.

The Bigger Picture

The stress system is not monolithic. Different CRF receptors mediate different aspects of the stress response, enabling precision medicine for stress-related disorders.

What This Study Doesn't Tell Us

Brief review. Clinical validation of CRF receptor-selective drugs was still limited. Some proposed receptor functions were based on animal data.

Questions This Raises

  • ?Can CRF2 agonists help with stress resilience?
  • ?Do urocortins play a role in normal appetite regulation?
  • ?Could CRF receptor profiling predict which stress disorders a patient will develop?

Trust & Context

Key Stat:
Two receptors, two roles CRF1 drives anxiety/depression while CRF2 aids stress coping and appetite regulation — different targets for different disorders
Evidence Grade:
Moderate evidence from a review integrating new peptide discovery with receptor pharmacology and proposed clinical applications.
Study Age:
Published in 2002. CRF receptor-selective drugs have been further developed, though clinical success has been mixed.
Original Title:
The CRF peptide family and their receptors: yet more partners discovered.
Published In:
Trends in pharmacological sciences, 23(2), 71-7 (2002)
Database ID:
RPEP-00723

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Is stress just one system in the body?

No. The CRF system has at least two receptors with different roles: CRF1 triggers anxiety and fear, while CRF2 helps the body cope with and recover from stress. This means different stress problems need different treatments.

What are urocortins?

Newly discovered cousins of CRF that preferentially activate the CRF2 receptor. They help with stress adaptation, appetite regulation, and cardiovascular adjustments — the 'recovery' side of the stress response.

Read More on RethinkPeptides

Cite This Study

RPEP-00723·https://rethinkpeptides.com/research/RPEP-00723

APA

Dautzenberg, Frank M; Hauger, Richard L. (2002). The CRF peptide family and their receptors: yet more partners discovered.. Trends in pharmacological sciences, 23(2), 71-7.

MLA

Dautzenberg, Frank M, et al. "The CRF peptide family and their receptors: yet more partners discovered.." Trends in pharmacological sciences, 2002.

RethinkPeptides

RethinkPeptides Research Database. "The CRF peptide family and their receptors: yet more partner..." RPEP-00723. Retrieved from https://rethinkpeptides.com/research/dautzenberg-2002-the-crf-peptide-family

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.